A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...

Acute flares in patients with RA were linked to higher risk for AD/ADRD, but the relationship was not significant.

A collaborative team of researchers has succeeded in revealing the high-resolution structures of amyloid β (Aβ40) fibrils ...

PRESS RELEASE NEW PEER-REVIEWED DATA PROVIDE STRONG EVIDENCE SUPPORTING MASITINIB'S POTENTIAL FOR THE TREATM ...

In 2023, neurologists at a memory clinic in China diagnosed a 19-year-old with what they believed to be Alzheimer's disease – ...

"The scale at which we analyzed the amyloid peptides was unprecedented," said Ben Lehner of the Wellcome Sanger Institute.

Dementia prevalence in India is rising, with experts emphasizing comprehensive evaluations, reversible causes, and global therapy advances.

New study tests Parkinson’s drug to treat early-onset familial Alzheimer’s disease, a rare form of dementia, with results expected by 2028 Fatma Zehra Solmaz | 03.06.2025 - Update : 04.06.2025 ...

The slow loss of memory, thinking, and independence that defines Alzheimer’s disease continues to affect millions worldwide. One rare but revealing form of the condition, known as familial ...

The first evidence that removing amyloid plaques may delay Alzheimer’s symptoms has now been published. In The Lancet Neurology on March 19, scientists led by Randall Bateman at Washington University ...

Among 53 asymptomatic people with dominantly inherited Alzheimer's disease who were treated with investigational gantenerumab in either the double-blind portion or open-label extension of a DIAN ...

This puts them into the category of familial Alzheimer's disease (FAD). In the case of young people, the likely cause is a faulty gene.